Alert

Recommended Alerts

Sign Up For Alerts

DEA Announces Proposed Expansion of Controlled Substance Monitoring Requirements

On November 2, 2020, the Drug Enforcement Administration (“DEA”) issued a notice of proposed rulemaking expanding the obligations of DEA registrants to monitor and report suspicious orders for controlled substances (the “Proposal”). The Proposal sets forth a two-option framework for reviewing and reporting suspicious orders, adds new reporting and recordkeeping requirements, and expands the scope of suspicious order monitoring obligations to cover certain hospitals, practitioners and other dispensers. Notably, the Proposal asserts that those hospitals, practitioners and dispensers should already be in compliance with the purported requirements.

Read More

Delaware Court Decision Changes Expectations for Directors' Indemnification and Advancement Rights


Time to Read: 1 minutes Practices: Litigation, Corporate & Securities Litigation, Securities & Public Companies

Printer-Friendly Version

The litigation risks facing private equity firms and their portfolio companies have increased significantly in the last several years. Until recently, the widespread expectation of private equity investors whose principals sit on the board of directors of a sponsor's portfolio company has been that, in the event of litigation against the sponsor's director designees, the portfolio company would provide full advancement and indemnification to the sponsor's designee(s), with the private equity sponsor providing such advancement or indemnification only in the event that the portfolio company is legally or financially unable to pay. A single Delaware Chancery Court decision has, however, disrupted this settled expectation and, in so doing, raised the financial stakes faced by private equity firms and their principals in the event of litigation.

In the attached article, "Director and Officer Liability: Delaware Reinforces the Limits on Indemnification Claims," Ropes & Gray partner Randall Bodner and associate Peter Welsh discuss the implications of the Levy v. HLI Operating Co. decision on the indemnification and advancement rights of private equity firms' board designees. The authors also suggest potential work-arounds to the issues raised by the Levy decision. One of the work-arounds the authors discuss was recently embraced by the Delaware Chancery Court in Sadona v. American Stock Exchange, which was issued after the attached article was written. 

Printer-Friendly Version

Cookie Settings